A Democratic-led New York state legislature passed the Reproductive Health Care Act by a margin of 38 to 24, and Governor Andrew Cuomo signed it into law on 22 January 2019.
Update In December 2018, the U.S. Food and Drug Administration (FDA) granted clearance to market the Embrace smartband for seizure-monitoring use in children. Embrace is the first non-EEG (non-electroencephalogram) based physiology signal seizure monitoring system to be cleared by the FDA for use in children 6 years old and older.
